What drove the increase in net sales for the third quarter of 2009?

Net sales increased by 2.0% to $23.3 million in the third quarter of 2009 compared to the prior year. This growth was primarily attributed to an increase in sales to the U.S. Federal government, including an order from U.S. Customs and Border Patrol, and strong international sales, particularly follow-on orders from customers in Australia. These increases helped offset a decline in domestic sales, which management believes is due to lower municipal spending resulting from economic conditions.

Why did the company report a net loss in Q3 2009 after reporting a profit in Q3 2008?

The company reported a net loss of $3.2 million in the third quarter of 2009, a reversal from a net income of $0.65 million in the same quarter of 2008. This was primarily due to a significant increase in operating expenses. Research and Development (R&D) expenses more than doubled year-over-year, driven by investments in new product development for the TASER X3 and AXON systems, as well as the EVIDENCE.com platform. Sales, General, and Administrative (SG&A) expenses also rose considerably, influenced by increased headcount to support business expansion, higher stock-based compensation costs, and expanded sales and marketing efforts for new product launches.

How did the trade-in program affect the financial results?

The company introduced a temporary trade-in program in July 2009, allowing agencies purchasing a TASER X26 ECD to upgrade to the new TASER X3 ECD for a partial credit. This program resulted in $3.5 million of revenue being deferred as of September 30, 2009, impacting reported net sales and gross margin for the third quarter. The deferred revenue is expected to be recognized either when the trade-in occurs in the fourth quarter or when the offer expires at year-end.

What is the company's liquidity position and outlook?

Axon Enterprise, Inc. maintains a strong liquidity position. As of September 30, 2009, the company held $45.4 million in cash and cash equivalents. Additionally, it has a $10 million revolving credit facility available, with no amounts outstanding at that time. Management believes these resources, combined with expected cash flow from operations, are sufficient to fund operations and strategic initiatives for at least the next 12 months. The company also notes potential needs for additional resources to expedite manufacturing for new and existing technologies.

AXON 10-Q Quarterly Report Q3 FY2009 — Revenue, Net Income, EPS

Summary

Axon Enterprise, Inc. (formerly TASER International, Inc.) reported net sales of $23.3 million for the third quarter of 2009, a modest 2.0% increase compared to the same period in 2008. This growth was primarily driven by an increase in federal business and international sales, which offset a decline in domestic municipal spending attributed to economic constraints. A new trade-in program for the TASER X26 ECD, offering an upgrade to the X3 ECD, deferred $3.5 million in revenue, impacting reported sales and gross margins. The company experienced a net loss of $3.2 million for the quarter, a significant decrease from the $0.65 million net income reported in Q3 2008, largely due to increased operating expenses, particularly in research and development and sales, general, and administrative categories, as the company invested in new product development and business infrastructure. For the first nine months of 2009, net sales increased by 5.0% to $69.7 million, again bolstered by international and federal sales, which countered weaker domestic demand. However, the company incurred a net loss of $4.4 million for this period, compared to a smaller net loss of $0.15 million in the prior year. This widened loss was primarily driven by substantial increases in R&D expenses related to new product development (TASER X3, AXON, EVIDENCE.com) and higher SG&A costs, including significant stock-based compensation expenses and costs associated with strategic initiatives. The company maintains a strong liquidity position with $45.4 million in cash and cash equivalents and an undrawn $10 million credit facility, indicating financial stability to fund operations and planned investments.

Key Highlights

1Net sales increased by 2.0% to $23.3 million in Q3 2009, driven by federal and international business, partially offset by domestic weakness.
2A new trade-in program resulted in $3.5 million in deferred revenue in Q3 2009, impacting reported sales and gross margins.
3The company reported a net loss of $3.2 million in Q3 2009, a significant decline from a net income of $0.65 million in Q3 2008, due to increased operating expenses.
4For the nine months ended September 30, 2009, net sales grew 5.0% to $69.7 million, with international and federal segments showing strength.
5Research and development expenses surged by 80.1% year-to-date to $15.2 million, primarily due to new product development (X3, AXON, EVIDENCE.com).
6Sales, General & Administrative (SG&A) expenses increased by 20.6% year-to-date to $33.7 million, driven by headcount expansion, stock-based compensation, and strategic initiatives.
7The company ended the quarter with $45.4 million in cash and cash equivalents and had $10 million available on its credit facility, indicating a healthy liquidity position.

AXON ENTERPRISE, INC. Quarterly Report for Q3 Ended Sep 30, 2009

Summary

Key Highlights

Frequently Asked Questions